Medical Program: Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type

Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type

Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
RestartResume

How can we use a non-small cell cancer patient’s cancer type and genomic makeup to our advantage when creating treatment plans?

  • Overview

    Thanks to recent research, we can now use a non-small cell cancer patient’s cancer type and genomic makeup to create targeted treatment plans. Joining Dr. Paul Doghramji to share what that approach looks like in practice is Dr. Edward Kim, the Chair of Solid Tumor Oncology and Investigational Therapeutics at the Levine Cancer Institute Atrium Health in Charlotte, North Carolina.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free